MARKET

CVM

CVM

CEL-SCI Corp
AMEX
1.110
+0.136
+13.92%
After Hours: 1.060 -0.05 -4.50% 19:39 06/26 EDT
OPEN
1.000
PREV CLOSE
0.9744
HIGH
1.110
LOW
0.9900
VOLUME
330.71K
TURNOVER
--
52 WEEK HIGH
13.48
52 WEEK LOW
0.8900
MARKET CAP
19.40M
P/E (TTM)
-0.3101
1D
5D
1M
3M
1Y
5Y
1D
CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026
TipRanks · 4d ago
Weekly Report: what happened at CVM last week (0615-0619)?
Weekly Report · 6d ago
CEL-SCI highlights dual-track strategy for Multikine
TipRanks · 06/16 12:14
CEL-SCI Announces Dual-Track Strategy To Bring Multikine To Patients With Head And Neck Cancer Through Parallel Regulatory Pathways In The U.S. And Saudi Arabia
Benzinga · 06/16 12:08
Weekly Report: what happened at CVM last week (0608-0612)?
Weekly Report · 06/15 09:49
CEL-SCI slides after pricing $2.5M best-efforts common stock offering at $1.00/share
Seeking Alpha · 06/15 08:59
CEL-SCI, Saudi Amarox to conduct signing ceremony for strategic agreement
TipRanks · 06/12 12:11
CEL‑SCI To Sign Saudi Amarox Deal At BIO International Convention 2026, Advancing Multikine Commercialization In Saudi Arabia
Benzinga · 06/12 12:02
More
About CVM
CEL-SCI Corporation is a late clinical-stage biotechnology company. It is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. It is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS). Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. LEAPS is designed to stimulate the human immune system to more effectively fight bacterial, viral and parasitic infections as well as autoimmune conditions, allergies, transplantation rejection and cancer, when it cannot do so on its own. The LEAPS candidates include CEL-2000, CEL-4000 and DerG-PG275(Cit) (aka, CEL-5000).

Webull offers CEL-SCI Corp stock information, including AMEX: CVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CVM stock methods without spending real money on the virtual paper trading platform.